Healthcare AI Exits Pilot Phase, Enters Production Deployment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
BofA Securities on Doximity Inc (DOCS): 'No shift from DTC, but HCP growth is accelerating'
December 16, 2025 6:00 AM ESTBofA Securities analyst Allen Lutz reiterated a Buy rating and $82.00 price target on Doximity Inc (NYSE: DOCS).
The analyst comments "Yesterday, we hosted a conference call on pharma ad budgets with two industry executives, Andrew McLean, and Stuart Klein (bios below).... More



